Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid (Rituximab2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00525616
Recruitment Status : Completed
First Posted : September 6, 2007
Last Update Posted : September 8, 2014
Information provided by (Responsible Party):
University Hospital, Rouen

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : December 2013
  Study Completion Date : December 2013